Primary tumor location and efficacy of second-line therapy after initial treatment with FOLFIRI in combination with cetuximab or bevacizumab in patients with metastatic colorectal cancer- FIRE-3 (AIOKRK0306).
暂无分享,去创建一个
W. Scheithauer | M. Stauch | V. Heinemann | T. Decker | A. Kiani | S. Al-Batran | T. Kirchner | A. Jung | S. Stintzing | F. Kullmann | T. Heintges | G. Seipelt | C. Kahl | D. Modest | L. F. V. Weikersthal | S. Held | U. Vehling‐Kaiser | C. Gießen-Jung